Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence
F Ahmed, MC Lindley, N Allred… - Clinical infectious …, 2014 - academic.oup.com
Background. Influenza vaccination of healthcare personnel (HCP) is recommended in> 40
countries. However, there is controversy surrounding the evidence that HCP vaccination …
countries. However, there is controversy surrounding the evidence that HCP vaccination …
Benefits of flu vaccination for persons with diabetes mellitus: a review
Diabetes mellitus imposes a significant and increasing burden on society, with major
consequences for human health, welfare and the economy worldwide. Persons with …
consequences for human health, welfare and the economy worldwide. Persons with …
Protection against omicron (B. 1.1. 529) BA. 2 reinfection conferred by primary omicron BA. 1 or pre-omicron SARS-CoV-2 infection among health-care workers with …
Background There is a paucity of data on vaccine-induced or infection-induced (hybrid or
natural) immunity against omicron (B. 1.1. 529) subvariant BA. 2, particularly in comparing …
natural) immunity against omicron (B. 1.1. 529) subvariant BA. 2, particularly in comparing …
Estimated protection of prior SARS-CoV-2 infection against reinfection with the Omicron variant among messenger RNA–vaccinated and nonvaccinated individuals in …
Importance The Omicron variant is phylogenetically and antigenically distinct from earlier
SARS-CoV-2 variants and the original vaccine strain. Protection conferred by prior SARS …
SARS-CoV-2 variants and the original vaccine strain. Protection conferred by prior SARS …
Low 2012–13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses
Background Influenza vaccine effectiveness (VE) is generally interpreted in the context of
vaccine match/mismatch to circulating strains with evolutionary drift in the latter invoked to …
vaccine match/mismatch to circulating strains with evolutionary drift in the latter invoked to …
Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness
SG Sullivan, EJ Tchetgen Tchetgen… - American journal of …, 2016 - academic.oup.com
Influenza viruses undergo frequent antigenic changes. As a result, the viruses circulating
change within and between seasons, and the composition of the influenza vaccine is …
change within and between seasons, and the composition of the influenza vaccine is …
The test-negative design for estimating influenza vaccine effectiveness
ML Jackson, JC Nelson - Vaccine, 2013 - Elsevier
Objective The test-negative design has emerged in recent years as the preferred method for
estimating influenza vaccine effectiveness (VE) in observational studies. However, the …
estimating influenza vaccine effectiveness (VE) in observational studies. However, the …
Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates
SE Ohmit, MG Thompson, JG Petrie… - Clinical infectious …, 2014 - academic.oup.com
Background. Each year, the US Influenza Vaccine Effectiveness Network examines the
effectiveness of influenza vaccines in preventing medically attended acute respiratory …
effectiveness of influenza vaccines in preventing medically attended acute respiratory …
Impact of repeated vaccination on vaccine effectiveness against influenza A (H3N2) and B during 8 seasons
HQ McLean, MG Thompson… - Clinical infectious …, 2014 - academic.oup.com
The effect of prior influenza vaccination history on vaccine effectiveness was assessed in a
community cohort over 8 seasons. Current-and previous-season vaccination generated …
community cohort over 8 seasons. Current-and previous-season vaccination generated …
Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre …
M Suzuki, BG Dhoubhadel, T Ishifuji… - The Lancet infectious …, 2017 - thelancet.com
Background The serotype-specific effectiveness of 23-valent pneumococcal polysaccharide
vaccine (PPV23) against pneumococcal pneumonia has not been established in people …
vaccine (PPV23) against pneumococcal pneumonia has not been established in people …